Osteogenics Biomedical

Founded in 1996 and headquartered in Lubbock, TX, Osteogenics Biomedical has grown into a leader in the dental bone grafting industry, serving Periodontists, Oral & Maxillofacial Surgeons and clinicians involved in regenerative and implant dentistry throughout the world. The company’s core brands include enCore® Combination and Mineralized Allografts, Cytoplast™ barrier membranes, Cytoplast™ PTFE suture, Pro-fix™, and Osteogenics Clinical Education.